Cargando…

Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study

CONTEXT: Depression is associated with increased mortality, but it is unclear if this relationship is dose-dependent and if it can be modified by treatment with antidepressants. OBJECTIVE: To determine if (1) the association between depression and mortality is independent of other common potential c...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Osvaldo P., Alfonso, Helman, Hankey, Graeme J., Flicker, Leon
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890408/
https://www.ncbi.nlm.nih.gov/pubmed/20585644
http://dx.doi.org/10.1371/journal.pone.0011266
_version_ 1782182787943497728
author Almeida, Osvaldo P.
Alfonso, Helman
Hankey, Graeme J.
Flicker, Leon
author_facet Almeida, Osvaldo P.
Alfonso, Helman
Hankey, Graeme J.
Flicker, Leon
author_sort Almeida, Osvaldo P.
collection PubMed
description CONTEXT: Depression is associated with increased mortality, but it is unclear if this relationship is dose-dependent and if it can be modified by treatment with antidepressants. OBJECTIVE: To determine if (1) the association between depression and mortality is independent of other common potential causes of death in later life, (2) there is a dose-response relationship between increasing severity of depression and mortality rates, and (3) the use of antidepressant drugs reduces mortality rates. METHODS: Cohort study of 5,276 community-dwelling men aged 68–88 years living in Perth, Australia. We used the Geriatric Depression Scale 15-items (GDS-15) to ascertain the presence and severity of depression. GDS-15≥7 indicates the presence of clinically significant depression. Men were also grouped according to the severity of symptoms: “no symptoms” (GDS-15 = 0), “questionable” (1≤GDS-15≤4), “mild to moderate” (5≤GDS-15≤9), and “severe” (GDS-15≥10). Participants listed all medications used regularly. We used the Western Australian Data Linkage System to monitor mortality. RESULTS: There were 883 deaths between the study assessment and the 30th June 2008 (mean follow-up of participants: 6.0±1.1 years). The adjusted mortality hazard (MH) of men with clinically significant depression was 1.98 (95%CI = 1.61–2.43), and increased with the severity of symptoms: 1.39 (95%CI = 1.13–1.71) for questionable, 2.71 (95%CI = 2.13–3.46) for mild/moderate, and 3.32 (95%CI: 2.31–4.78) for severe depression. The use of antidepressants increased MH (HR = 1.31, 95%CI = 1.02–1.68). Compared with men who were not depressed and were not taking antidepressants, MH increased from 1.22 (95%CI = 0.91–1.63) for men with no depression who were using antidepressants to 1.85 (95%CI = 1.47–2.32) for participants who were depressed but were not using antidepressants, and 2.97 (95%CI = 1.94–4.54) for those who were depressed and were using antidepressants. All analyses were adjusted for age, educational attainment, migrant status, physical activity, smoking and alcohol use and the Charlson comorbidity index. CONCLUSIONS: The mortality associated with depression increases with the severity of depressive symptoms and is largely independent of comorbid conditions. The use of antidepressants does not reduce the mortality rates of older men with persistent symptoms of depression.
format Text
id pubmed-2890408
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28904082010-06-28 Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study Almeida, Osvaldo P. Alfonso, Helman Hankey, Graeme J. Flicker, Leon PLoS One Research Article CONTEXT: Depression is associated with increased mortality, but it is unclear if this relationship is dose-dependent and if it can be modified by treatment with antidepressants. OBJECTIVE: To determine if (1) the association between depression and mortality is independent of other common potential causes of death in later life, (2) there is a dose-response relationship between increasing severity of depression and mortality rates, and (3) the use of antidepressant drugs reduces mortality rates. METHODS: Cohort study of 5,276 community-dwelling men aged 68–88 years living in Perth, Australia. We used the Geriatric Depression Scale 15-items (GDS-15) to ascertain the presence and severity of depression. GDS-15≥7 indicates the presence of clinically significant depression. Men were also grouped according to the severity of symptoms: “no symptoms” (GDS-15 = 0), “questionable” (1≤GDS-15≤4), “mild to moderate” (5≤GDS-15≤9), and “severe” (GDS-15≥10). Participants listed all medications used regularly. We used the Western Australian Data Linkage System to monitor mortality. RESULTS: There were 883 deaths between the study assessment and the 30th June 2008 (mean follow-up of participants: 6.0±1.1 years). The adjusted mortality hazard (MH) of men with clinically significant depression was 1.98 (95%CI = 1.61–2.43), and increased with the severity of symptoms: 1.39 (95%CI = 1.13–1.71) for questionable, 2.71 (95%CI = 2.13–3.46) for mild/moderate, and 3.32 (95%CI: 2.31–4.78) for severe depression. The use of antidepressants increased MH (HR = 1.31, 95%CI = 1.02–1.68). Compared with men who were not depressed and were not taking antidepressants, MH increased from 1.22 (95%CI = 0.91–1.63) for men with no depression who were using antidepressants to 1.85 (95%CI = 1.47–2.32) for participants who were depressed but were not using antidepressants, and 2.97 (95%CI = 1.94–4.54) for those who were depressed and were using antidepressants. All analyses were adjusted for age, educational attainment, migrant status, physical activity, smoking and alcohol use and the Charlson comorbidity index. CONCLUSIONS: The mortality associated with depression increases with the severity of depressive symptoms and is largely independent of comorbid conditions. The use of antidepressants does not reduce the mortality rates of older men with persistent symptoms of depression. Public Library of Science 2010-06-23 /pmc/articles/PMC2890408/ /pubmed/20585644 http://dx.doi.org/10.1371/journal.pone.0011266 Text en Almeida et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Almeida, Osvaldo P.
Alfonso, Helman
Hankey, Graeme J.
Flicker, Leon
Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
title Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
title_full Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
title_fullStr Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
title_full_unstemmed Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
title_short Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
title_sort depression, antidepressant use and mortality in later life: the health in men study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890408/
https://www.ncbi.nlm.nih.gov/pubmed/20585644
http://dx.doi.org/10.1371/journal.pone.0011266
work_keys_str_mv AT almeidaosvaldop depressionantidepressantuseandmortalityinlaterlifethehealthinmenstudy
AT alfonsohelman depressionantidepressantuseandmortalityinlaterlifethehealthinmenstudy
AT hankeygraemej depressionantidepressantuseandmortalityinlaterlifethehealthinmenstudy
AT flickerleon depressionantidepressantuseandmortalityinlaterlifethehealthinmenstudy